Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Short-term Investments (2017 - 2019)

Historic Short-term Investments for Cogent Biosciences (COGT) over the last 3 years, with Q1 2019 value amounting to $8.0 million.

  • Cogent Biosciences' Short-term Investments rose 1931.0% to $8.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $8.0 million, marking a year-over-year increase of 1931.0%. This contributed to the annual value of $22.9 million for FY2018, which is 8062.41% up from last year.
  • As of Q1 2019, Cogent Biosciences' Short-term Investments stood at $8.0 million, which was up 1931.0% from $22.9 million recorded in Q4 2018.
  • Cogent Biosciences' Short-term Investments' 5-year high stood at $47.7 million during Q2 2018, with a 5-year trough of $6.7 million in Q1 2018.
  • For the 3-year period, Cogent Biosciences' Short-term Investments averaged around $22.6 million, with its median value being $17.8 million (2017).
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 8062.41% in 2018, then surged by 1931.0% in 2019.
  • Quarter analysis of 3 years shows Cogent Biosciences' Short-term Investments stood at $12.7 million in 2017, then surged by 80.62% to $22.9 million in 2018, then plummeted by 65.15% to $8.0 million in 2019.
  • Its Short-term Investments stands at $8.0 million for Q1 2019, versus $22.9 million for Q4 2018 and $37.8 million for Q3 2018.